Machine learnINg for the rElapse Risk eValuation in Acute Biliary Pancreatitis.
Condition(s):Acute Pancreatitis; Pancreatitis Due to Gallstones; Pancreatitis Biliary; Pancreatitis RelapsingLast Updated:November 9, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Acute Pancreatitis; Pancreatitis Due to Gallstones; Pancreatitis Biliary; Pancreatitis RelapsingLast Updated:November 9, 2023Not yet recruiting
Condition(s):Atrial Fibrillation; Arrhythmias, CardiacLast Updated:November 22, 2023Recruiting
Condition(s):HypertensionLast Updated:June 6, 2022Not yet recruiting
Condition(s):MyelomaLast Updated:January 11, 2022Unknown status
Condition(s):NSTEMI – Non-ST Segment Elevation MI; Unstable AnginaLast Updated:December 31, 2020Unknown status
Condition(s):Chemotherapeutic ToxicityLast Updated:September 21, 2023Completed
Condition(s):COVID-19; Post-COVID-19 Syndrome; InfluenzaLast Updated:December 29, 2023Completed
Condition(s):Eye DiseasesLast Updated:November 21, 2023Completed
Condition(s):Acute Hypoxemic Respiratory FailureLast Updated:March 27, 2024Active, not recruiting
Condition(s):Covid19Last Updated:April 2, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.